[1] 庄远,汪德清.传统血浆置换治疗如何适应现代医学的发展[J].临床输血与检验,2020,22(5):472-476. [2] CLARK W F,HUANG S S.Introduction to therapeutic plasma exchange[J].Transfus Apher Sci,2019,58(3): 228-229. [3] LI B J,YANG X S,PENG J J,et al.Lymphoplasmapheres is for guillain-barre syndrome[J].Zhong Nan Da Xue Xue Bao Yi Xue Ban,2007,32(4):604-608. [4] 王毅. ABO血型不相容亲属活体肾移植临床诊疗指南(2017版)[J].中华移植杂志(电子版),2017,11(4):193-200. [5] 李碧娟,杨晓苏,彭晶晶,等.淋巴血浆置换治疗吉兰-巴雷综合征的临床应用[J].中南大学学报(医学版),2007,32(4):604-608. [6] 郑斌,李爱华,陈运贤.淋巴细胞清除并血浆置换术治疗多发性骨髓瘤的疗效观察[J].肿瘤防治研究,2004,31(8):501-503. [7] 饶诗佳,李碧娟,李吉,等.淋巴血浆置换疗法治疗难治性重症免疫相关性皮肤病疗效观察[J].中华皮肤科杂志,2019,52(1):16-19. [8] WANG B,LI J,XIE H F,et al.Striking case of Febrile ulceronecrotic Mucha-Habermann disease responding to lymphoplasmapheresis and methotrexate[J].J Dermatol,2020,47(12):e430-e431. [9] YU J H,CHUNG B H,YANG C W,et al.Impact of ABO incompatible kidney transplantation on living donor transplantation[J].PLoS One,2017,12(3):e0173878. [10] BARNETT A N,MANOOK M,NAGENDRAN M,et al.Tailored desensitization strategies in ABO blood group antibody incompatible renal transplantation[J].Transpl Int,2014,27(2):187-196. [11] MORATH C,ZEIER M,DÖHLER B,et al.ABO-incompatible kidney transplantation[J].Front Immunol,2017,8:234. [12] BELL A M,NOLEN J D,KNUDSON C M,et al.Severe citrate toxicity complicating volunteer apheresis platelet donation[J].J Clin Apher,2007,22(1):15-16. |